Migratory activity of circulating progenitor cells and serum SDF-1α predict adverse events in patients with myocardial infarction

Orazio Fortunato, Gaia Spinetti, Claudia Specchia, Elisa Cangiano, Marco Valgimigli, Paolo Madeddu

Research output: Contribution to journalArticle

Abstract

Aims: Following acute myocardial infarction (AMI), pro-angiogenic progenitor cells (PCs) are released from the bone marrow into the circulation and home to the ischaemic site attracted by a chemokine gradient. It is unknown if components of this early homeostatic response might help forecast the long-term clinical outcome. This study investigates if the number and migratory activity of circulating PCs predict adverse events in patients with AMI (clinical trial: NCT01271309). Methods and results: Basal counts and in vitro migratory activity of CD34/CD45/CD133/CXCR4 PCs and serum cytokine levels were assessed during the first 5 days after AMI in a consecutive series of 172 patients. Clinical outcomes of the study were death, repeat AMI, and new-onset heart failure at a 1-year follow-up. The association between PC counts and cytokine levels with the incidence of clinical outcomes was assessed by multivariable regression models. AMI patients who underwent an event showed higher serum stromal cell-derived factor 1α (SDF-1α) levels and reduced spontaneous motility of PCs in an in vitro migration assay when compared with event-free subjects. After adjustment for age, gender, the presence or absence of ST elevation, or diabetes, the percentage of PCs non-migrated towards vehicle or SDF-1α were both independent predictors of death or repeat AMI and new-onset heart failure (odds ratio [OR] = 2, P = 0.015 and OR = 1.90, P = 0.018, respectively). Moreover, serum SDF-1α levels predict adverse events (OR = 3.8, P = 0.007). Conclusion: Biomarkers reflecting the migratory activity of circulating PCs may aid the assessment of secondary risk in AMI patients.

Original languageEnglish
Pages (from-to)192-200
Number of pages9
JournalCardiovascular Research
Volume100
Issue number2
DOIs
Publication statusPublished - Nov 1 2013

Fingerprint

Chemokine CXCL12
Stem Cells
Myocardial Infarction
Serum
Odds Ratio
Heart Failure
Cytokines
Chemokines
Cell Count
Biomarkers
Bone Marrow
Outcome Assessment (Health Care)
Clinical Trials
Incidence

Keywords

  • Acute myocardial infarction
  • Circulating progenitor cells
  • Migration
  • SDF-1α

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)
  • Physiology

Cite this

Migratory activity of circulating progenitor cells and serum SDF-1α predict adverse events in patients with myocardial infarction. / Fortunato, Orazio; Spinetti, Gaia; Specchia, Claudia; Cangiano, Elisa; Valgimigli, Marco; Madeddu, Paolo.

In: Cardiovascular Research, Vol. 100, No. 2, 01.11.2013, p. 192-200.

Research output: Contribution to journalArticle

@article{a63a2ce050444befb97cb336059ba2a7,
title = "Migratory activity of circulating progenitor cells and serum SDF-1α predict adverse events in patients with myocardial infarction",
abstract = "Aims: Following acute myocardial infarction (AMI), pro-angiogenic progenitor cells (PCs) are released from the bone marrow into the circulation and home to the ischaemic site attracted by a chemokine gradient. It is unknown if components of this early homeostatic response might help forecast the long-term clinical outcome. This study investigates if the number and migratory activity of circulating PCs predict adverse events in patients with AMI (clinical trial: NCT01271309). Methods and results: Basal counts and in vitro migratory activity of CD34/CD45/CD133/CXCR4 PCs and serum cytokine levels were assessed during the first 5 days after AMI in a consecutive series of 172 patients. Clinical outcomes of the study were death, repeat AMI, and new-onset heart failure at a 1-year follow-up. The association between PC counts and cytokine levels with the incidence of clinical outcomes was assessed by multivariable regression models. AMI patients who underwent an event showed higher serum stromal cell-derived factor 1α (SDF-1α) levels and reduced spontaneous motility of PCs in an in vitro migration assay when compared with event-free subjects. After adjustment for age, gender, the presence or absence of ST elevation, or diabetes, the percentage of PCs non-migrated towards vehicle or SDF-1α were both independent predictors of death or repeat AMI and new-onset heart failure (odds ratio [OR] = 2, P = 0.015 and OR = 1.90, P = 0.018, respectively). Moreover, serum SDF-1α levels predict adverse events (OR = 3.8, P = 0.007). Conclusion: Biomarkers reflecting the migratory activity of circulating PCs may aid the assessment of secondary risk in AMI patients.",
keywords = "Acute myocardial infarction, Circulating progenitor cells, Migration, SDF-1α",
author = "Orazio Fortunato and Gaia Spinetti and Claudia Specchia and Elisa Cangiano and Marco Valgimigli and Paolo Madeddu",
year = "2013",
month = "11",
day = "1",
doi = "10.1093/cvr/cvt153",
language = "English",
volume = "100",
pages = "192--200",
journal = "Cardiovascular Research",
issn = "0008-6363",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Migratory activity of circulating progenitor cells and serum SDF-1α predict adverse events in patients with myocardial infarction

AU - Fortunato, Orazio

AU - Spinetti, Gaia

AU - Specchia, Claudia

AU - Cangiano, Elisa

AU - Valgimigli, Marco

AU - Madeddu, Paolo

PY - 2013/11/1

Y1 - 2013/11/1

N2 - Aims: Following acute myocardial infarction (AMI), pro-angiogenic progenitor cells (PCs) are released from the bone marrow into the circulation and home to the ischaemic site attracted by a chemokine gradient. It is unknown if components of this early homeostatic response might help forecast the long-term clinical outcome. This study investigates if the number and migratory activity of circulating PCs predict adverse events in patients with AMI (clinical trial: NCT01271309). Methods and results: Basal counts and in vitro migratory activity of CD34/CD45/CD133/CXCR4 PCs and serum cytokine levels were assessed during the first 5 days after AMI in a consecutive series of 172 patients. Clinical outcomes of the study were death, repeat AMI, and new-onset heart failure at a 1-year follow-up. The association between PC counts and cytokine levels with the incidence of clinical outcomes was assessed by multivariable regression models. AMI patients who underwent an event showed higher serum stromal cell-derived factor 1α (SDF-1α) levels and reduced spontaneous motility of PCs in an in vitro migration assay when compared with event-free subjects. After adjustment for age, gender, the presence or absence of ST elevation, or diabetes, the percentage of PCs non-migrated towards vehicle or SDF-1α were both independent predictors of death or repeat AMI and new-onset heart failure (odds ratio [OR] = 2, P = 0.015 and OR = 1.90, P = 0.018, respectively). Moreover, serum SDF-1α levels predict adverse events (OR = 3.8, P = 0.007). Conclusion: Biomarkers reflecting the migratory activity of circulating PCs may aid the assessment of secondary risk in AMI patients.

AB - Aims: Following acute myocardial infarction (AMI), pro-angiogenic progenitor cells (PCs) are released from the bone marrow into the circulation and home to the ischaemic site attracted by a chemokine gradient. It is unknown if components of this early homeostatic response might help forecast the long-term clinical outcome. This study investigates if the number and migratory activity of circulating PCs predict adverse events in patients with AMI (clinical trial: NCT01271309). Methods and results: Basal counts and in vitro migratory activity of CD34/CD45/CD133/CXCR4 PCs and serum cytokine levels were assessed during the first 5 days after AMI in a consecutive series of 172 patients. Clinical outcomes of the study were death, repeat AMI, and new-onset heart failure at a 1-year follow-up. The association between PC counts and cytokine levels with the incidence of clinical outcomes was assessed by multivariable regression models. AMI patients who underwent an event showed higher serum stromal cell-derived factor 1α (SDF-1α) levels and reduced spontaneous motility of PCs in an in vitro migration assay when compared with event-free subjects. After adjustment for age, gender, the presence or absence of ST elevation, or diabetes, the percentage of PCs non-migrated towards vehicle or SDF-1α were both independent predictors of death or repeat AMI and new-onset heart failure (odds ratio [OR] = 2, P = 0.015 and OR = 1.90, P = 0.018, respectively). Moreover, serum SDF-1α levels predict adverse events (OR = 3.8, P = 0.007). Conclusion: Biomarkers reflecting the migratory activity of circulating PCs may aid the assessment of secondary risk in AMI patients.

KW - Acute myocardial infarction

KW - Circulating progenitor cells

KW - Migration

KW - SDF-1α

UR - http://www.scopus.com/inward/record.url?scp=84886070256&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886070256&partnerID=8YFLogxK

U2 - 10.1093/cvr/cvt153

DO - 10.1093/cvr/cvt153

M3 - Article

C2 - 23761401

AN - SCOPUS:84886070256

VL - 100

SP - 192

EP - 200

JO - Cardiovascular Research

JF - Cardiovascular Research

SN - 0008-6363

IS - 2

ER -